Page 8 - Crown Bioscience News Today

Published: Jun 03, 2021     SAN DIEGO--(BUSINESS WIRE)-- Crown Biosciences Inc. (CrownBio), a JSR Life Sciences Company, today announced that they have entered into separate, yet complementary, portfolio license agreements with the ATCC and the U.S. Department of Health and Human Services, as represented by the National Cancer Institute (NCI) of the National Institute of Health (NIH). By entering into five-year agreements with these premier biomaterial resource providers, CrownBio clients...

This Animal Model market report depicts the global market scenario in terms of market size and revenue. Real time market condition and industry data i

CrownBio Acquires OcellO B.V. to Expand Its Preclinical In Vitro Drug Development Service Offerings Wednesday, May 5, 2021 6:55PM IST (1:25PM GMT) Acquisition augments CrownBio’s preclinical in vitro service platforms, adding high content imaging and advanced tumor organoid analytics to three-dimensional immuno-oncology drug assays   San Diego, United States:   Crown Bioscience (CrownBio), a JSR Life Sciences company and leader in...

FactMR: Animal Model Market Driven by Developments in Pharmaceutical and CRISPR Genetic Research, Opines Fact.MR Leading research organizations are investing increasingly in the use of advanced animal models for CRISPR and microinjection applications for long-term growth opportunities. NEW YORK, NY / ACCESSWIRE / April 14, 2021 / Fact.MR: The global revenue of animal model market will register a steady rate of growth through 2031, following substantial impetus emerging from drug and vaccine de...

Share this article Share this article ResearchAndMarkets.coms offering. The global in vivo toxicology market size is projected to reach USD 6.6 billion by 2025 from USD 5.0 billion in 2020, at a CAGR of 5.5% during the forecast period. Market growth is driven largely by the increasing pharmaceutical R&D activities, innovations in animal models, the development of exclusive in vivo toxicology tests, and the increasing demand for personalized medicine. By Product, the consumables segment accoun...

Search jobs 24-Feb-2021 CrownBio and JSR Life Sciences Partner with Cambridge Quantum Computing to Leverage Quantum Machine Learning for Novel Cancer Treatment Biomarker Discovery CrownBio and JSR Life Sciences Partner with Cambridge Quantum Computing to Leverage Quantum Machine Learning for Novel Cancer Treatment Biomarker Discovery     SUNNYVALE, California, CAMBRIDGE, UNITED KINGDOM, February 24, 2021 – Crown Bioscience (CrownBio), JSR Life Sc...

Next Generation Sequencing Market Size Worth $11.7 Billion By 2028: Grand View Research, Inc. to reach USD 11.7 billion by 2028 registering a CAGR of 14.4%, according to a new report by Grand View Research, Inc. As researchers are continuously unlocking the genetic diversity, the development of targeted therapies is on the rise. These therapies are targeted towards narrow populations of patients that have specific or rare genomic biomarkers. Therefore, this is expected to increase the utiliza...

26 Data Bridge Market Research has recently added a new research report to its mega database of research international studies. The research report, titled “PDX Models Market 2021” identifies and analyses the emerging trends along with major drivers, challenges market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels and opportunities in the market for PDX Models industry. For a thriving business, it is...

Search jobs 16-Feb-2021 Recombinant Protein Market Size Is Elastomers to Grow By 6.2% CAGR by 2025 | Global Industry Demand by Product, Application, Diagnostic Services and Treatment Recombinant Protein Market – Insights Recombinant proteins are used in development of novel therapies for severe chronic diseases such as cancer and other rare diseases. Recombinant protein production requires a special technique known as recombinant DNA (rDNA) technol...

China Digest: BangEr, Cothera, MAKE ESSENSE in funding news Premium Chinese specialized hospital chain operator BangEr Orthopedic, anti-tumour drug developer Cothera Bioscience, and men’s skincare brand MAKE ESSENSE have raked in new financing to expand operations.   Continue reading this story with a subscription to DealStreetAsia. Contact us for corporate subscriptions at subs@dealstreetasia.com. Sign up for our newsletter - The Daily Brief Opt out of...